{"nct_id":"NCT01232296","title":"A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment","status":"COMPLETED","status_verified_date":"2015-11","start_date":"2011-07","start_date_type":null,"primary_completion_date":"2014-04","primary_completion_date_type":"ACTUAL","completion_date":"2014-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}